Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Flagship Raises $824m To Speed Growth Of Its Portfolio Companies

Mar 22 2019

• By Mandy Jackson

Finance Watch

Related Content

Keeping Track: Rebuff Of Iclaprim Creates Early Pileup Of CRLs For Novel Drugs

Feb 19 2019

FINANCE ROUNDUP: Three IPOs and three VC rounds

Aug 08 2015

Venture Funding Deals, July 2015

Jul 09 2015

First Of Its Kind: Beam Seeks To Erase-And-Replace Single Letters In DNA's Alphabet

May 15 2018

China Investment Roundup: Strategic Overseas Moves Target Product Acquisitions

Jun 14 2017

IPO Update: Returns Run Red For Most Biopharma Firms That Went Public In The US Last Year

Jan 04 2019

Harmony Biosciences Raises $270m; Acquires US Rights To Narcolepsy Drug

Oct 06 2017

Finance Watch: Former Juno Execs Launch Sana With Allogeneic Cell Therapy Platform

Jan 07 2019

Finance Watch: Surrozen Raises $33m In $483m February Flurry; Also, Are Reverse Mergers This Year's IPOs?

Feb 28 2017

VC Roundup: Flagship’s New Fund Designed To Raise Its Stake In Startups

Dec 23 2016

Finance Watch: Panic Over FDA Commissioner's Resignation Was Short-Lived, Though IPOs Still Languish

Mar 18 2019

Related Companies

Bristol Myers Squibb Company

Foghorn Therapeutics Inc.

Evelo Biosciences, Inc.

Rubius Therapeutics, Inc.

Moderna, Inc.

Kaleido Biosciences, Inc.

Harmony Biosciences Holdings, Inc.

Beam Therapeutics Inc.

InventisBio, Inc.

Surrozen Inc.

Imago BioSciences, Inc.

Precision BioSciences, Inc.

CG Oncology, Inc.

Merck & Co., Inc.

University of California, Davis

Additional Topics

Financing StartUps and SMEs Innovation Business Strategies Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window